首页 > 最新文献

Turkish Thoracic Journal最新文献

英文 中文
Reduced Rate of Hospital Admission for Exacerbation of COPD and Asthma During COVID-19 Pandemic. COVID-19大流行期间COPD和哮喘加重住院率降低
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ.2021.20253
Serap Argun Baris, Hasim Boyaci, Huseyin Kaya, Ilknur Basyigit
We read with interest the article titled “Chronic Pulmonary Diseases and COVID-19” published in Turkish Thoracic Journal, signed by Ebru Çakır Edis.1 Despite we continued to serve during the COVID-19 outbreak, we noticed a decreased number of hospitalizations for airway diseases. Therefore, we conducted a study to investigate the impact of the COVID-19 outbreak on hospital admissions for exacerbations of chronic obstructive pulmonary disease (COPD) and asthma. Since we think it may contribute to our country’s data, we wanted to share the results with you.
{"title":"Reduced Rate of Hospital Admission for Exacerbation of COPD and Asthma During COVID-19 Pandemic.","authors":"Serap Argun Baris, Hasim Boyaci, Huseyin Kaya, Ilknur Basyigit","doi":"10.5152/TurkThoracJ.2021.20253","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2021.20253","url":null,"abstract":"We read with interest the article titled “Chronic Pulmonary Diseases and COVID-19” published in Turkish Thoracic Journal, signed by Ebru Çakır Edis.1 Despite we continued to serve during the COVID-19 outbreak, we noticed a decreased number of hospitalizations for airway diseases. Therefore, we conducted a study to investigate the impact of the COVID-19 outbreak on hospital admissions for exacerbations of chronic obstructive pulmonary disease (COPD) and asthma. Since we think it may contribute to our country’s data, we wanted to share the results with you.","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"510-511"},"PeriodicalIF":0.9,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975341/pdf/ttj-22-6-510.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39583523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Excess Deaths in Malatya in the COVID-19 Pandemic. 2019冠状病毒病大流行期间马拉迪亚的超额死亡人数。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ.2021.21039
Zeynep Ayfer Aytemur, Murat Yalçınsoy, Ahmet Kadir Arslan, Süleyman Savaş Hacıevliyagil

Objective: In our study, the effects of the COVID-19 pandemic in Malatya province, other than confirmed case deaths, were investigated.

Material and methods: The records of those who died between 2016 and 2020 were reviewed on the official website of the Malatya Metropolitan Municipality, and the numbers of deaths in those 5 years were recorded on a weekly basis. The arithmetic mean of the deaths between 2016 and 2019 was calculated, and it was investigated whether the number of deaths in 2020 was more than expected.

Results: In 2020, 1743 (61%) excess deaths were detected. While the mean number of deaths reported 4 years before 2020 was 2860, it was determined that the number of deaths in 2020 was 4603, and there were 1743 (61%) excess deaths.

Conclusion: The deaths occurred in Malatya during the COVID-19 pandemic were more than expected. It has been supposed that some deaths were of polymerase chain reaction negative and hence unrecorded COVID-19 patients' deaths, and some deaths were caused by other indirect effects of the pandemic.

目的:在我们的研究中,调查COVID-19大流行对马拉提亚省的影响,除了确诊病例死亡外。材料与方法:在马拉提亚市官方网站查阅2016 - 2020年死亡病例记录,每周记录5年死亡人数。计算2016年至2019年死亡人数的算术平均值,并调查2020年的死亡人数是否超过预期。结果:2020年共发现1743例(61%)超额死亡。虽然2020年前4年报告的平均死亡人数为2860人,但确定2020年的死亡人数为4603人,超额死亡人数为1743人(61%)。结论:2019冠状病毒病疫情期间马拉提亚地区死亡人数超出预期。据推测,一些死亡是聚合酶链反应阴性,因此未记录的COVID-19患者死亡,一些死亡是由大流行的其他间接影响造成的。
{"title":"Excess Deaths in Malatya in the COVID-19 Pandemic.","authors":"Zeynep Ayfer Aytemur,&nbsp;Murat Yalçınsoy,&nbsp;Ahmet Kadir Arslan,&nbsp;Süleyman Savaş Hacıevliyagil","doi":"10.5152/TurkThoracJ.2021.21039","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2021.21039","url":null,"abstract":"<p><strong>Objective: </strong>In our study, the effects of the COVID-19 pandemic in Malatya province, other than confirmed case deaths, were investigated.</p><p><strong>Material and methods: </strong>The records of those who died between 2016 and 2020 were reviewed on the official website of the Malatya Metropolitan Municipality, and the numbers of deaths in those 5 years were recorded on a weekly basis. The arithmetic mean of the deaths between 2016 and 2019 was calculated, and it was investigated whether the number of deaths in 2020 was more than expected.</p><p><strong>Results: </strong>In 2020, 1743 (61%) excess deaths were detected. While the mean number of deaths reported 4 years before 2020 was 2860, it was determined that the number of deaths in 2020 was 4603, and there were 1743 (61%) excess deaths.</p><p><strong>Conclusion: </strong>The deaths occurred in Malatya during the COVID-19 pandemic were more than expected. It has been supposed that some deaths were of polymerase chain reaction negative and hence unrecorded COVID-19 patients' deaths, and some deaths were caused by other indirect effects of the pandemic.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"473-476"},"PeriodicalIF":0.9,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975329/pdf/ttj-22-6-473.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39758464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Effect of Environmental Exposures on the Diagnosis of Tuberculosis in Syrian Refugees. 环境暴露对叙利亚难民肺结核诊断的影响。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ.2021.21158
Şerif Kurtuluş, Remziye Can

Objective: Humanitarian crisis in the Middle East geography has brought refugees into being. The aim of this study is to investigate the relationship between refugees' tuberculosis diagnosis process and air pollution parameters and environmental exposures.

Methods: A total of 229 patients with tuberculosis registered at Şanlıurfa Tuberculosis Dispensary during 2012-2018 were included. In this cross-sectional study, education levels, smoking status, warm-up style, and exposure to biomass, pesticides, dust storm, PM10, and sulfur dioxide were evaluated. Air parameters were received from https://www.havaizleme.gov.tr/. Bacteriological diagnosis was classified as smear-positive lung tuberculosis, smear-negative culture-positive lung tuberculosis, and other diagnostic methods. This study was approved by the Harran University Ethical Committee (10.12.2018; session: 12; decision no: 36).

Results: Of the 229 patients diagnosed with tuberculosis, 53.3% were males and 46.7% were females. The average age was 31.15 ± 15.16. About 24.5% of refugees lived in camps, while 75.5% lived outside of the camps. The rate of smear (+) lung tuberculosis was 38% and smear (-) culture (+) lung tuberculosis was 14.4%. Smoking (P = .007) in smear (+) cases and exposure to PM10 (P = .036) and sulfur dioxide (P = .015) in culture (+) cases were significant.

Conclusion: Smoking and air pollution are associated with delayed diagnosis of tuberculosis and severe forms of tuberculosis. We think that as a result of smoking cessation and reduction of air pollution, tuberculosis incidence in refugees can be reduced.

目的:中东地区的人道主义危机导致了难民的产生。本研究旨在探讨难民肺结核诊断过程与空气污染参数及环境暴露的关系。方法:选取2012-2018年在Şanlıurfa结核病药房登记的229例结核病患者。在这项横断面研究中,研究人员评估了受教育程度、吸烟状况、热身方式以及暴露于生物质、农药、沙尘暴、PM10和二氧化硫中的情况。空气参数来自https://www.havaizleme.gov.tr/。细菌学诊断分为涂片阳性肺结核、涂片阴性培养阳性肺结核和其他诊断方法。本研究经哈兰大学伦理委员会批准(10.12.2018;会话:12个;第36号决定)。结果229例确诊结核病患者中,男性占53.3%,女性占46.7%。平均年龄31.15±15.16岁。约24.5%的难民住在难民营内,75.5%住在难民营外。涂片(+)肺结核占38%,涂片(-)培养(+)肺结核占14.4%。涂片(+)组吸烟(P = .007)、培养(+)组暴露于PM10 (P = .036)和二氧化硫(P = .015)有显著性差异。结论:吸烟和空气污染与结核病的延迟诊断和严重形式的结核病有关。我们认为,由于戒烟和减少空气污染,难民的结核病发病率可以降低。
{"title":"The Effect of Environmental Exposures on the Diagnosis of Tuberculosis in Syrian Refugees.","authors":"Şerif Kurtuluş,&nbsp;Remziye Can","doi":"10.5152/TurkThoracJ.2021.21158","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2021.21158","url":null,"abstract":"<p><strong>Objective: </strong>Humanitarian crisis in the Middle East geography has brought refugees into being. The aim of this study is to investigate the relationship between refugees' tuberculosis diagnosis process and air pollution parameters and environmental exposures.</p><p><strong>Methods: </strong>A total of 229 patients with tuberculosis registered at Şanlıurfa Tuberculosis Dispensary during 2012-2018 were included. In this cross-sectional study, education levels, smoking status, warm-up style, and exposure to biomass, pesticides, dust storm, PM10, and sulfur dioxide were evaluated. Air parameters were received from https://www.havaizleme.gov.tr/. Bacteriological diagnosis was classified as smear-positive lung tuberculosis, smear-negative culture-positive lung tuberculosis, and other diagnostic methods. This study was approved by the Harran University Ethical Committee (10.12.2018; session: 12; decision no: 36).</p><p><strong>Results: </strong>Of the 229 patients diagnosed with tuberculosis, 53.3% were males and 46.7% were females. The average age was 31.15 ± 15.16. About 24.5% of refugees lived in camps, while 75.5% lived outside of the camps. The rate of smear (+) lung tuberculosis was 38% and smear (-) culture (+) lung tuberculosis was 14.4%. Smoking (P = .007) in smear (+) cases and exposure to PM10 (P = .036) and sulfur dioxide (P = .015) in culture (+) cases were significant.</p><p><strong>Conclusion: </strong>Smoking and air pollution are associated with delayed diagnosis of tuberculosis and severe forms of tuberculosis. We think that as a result of smoking cessation and reduction of air pollution, tuberculosis incidence in refugees can be reduced.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"489-493"},"PeriodicalIF":0.9,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975346/pdf/ttj-22-6-489.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39583519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Approaches and Mortality in Acute Respiratory Failure due to Drowning. 溺水导致急性呼吸衰竭的治疗方法和死亡率。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ.2021.21086
Selin Çakmakcı, Begüm Ergan, Bilgin Cömert, Ali Necati Gökmen

Objective: Drowning is a process of submersion and can lead to respiratory failure. Annually, there are an estimated 320 000 deaths worldwide due to drowning, in addition to nonfatal drowning events. There are limited data for respiratory failure due to drowning and its prognosis in Turkey. The aim of this study was to identify the therapeutic modalities used for acute respiratory failure (ARF) due to drowning, and its prognosis in hospitalized patients.

Material and methods: All adult drowning cases (according to the International Classification of Disease (ICD) diagnosis code) who were admitted to either the emergency department (ED) or the intensive care units (ICU), or the pulmonology inpatient clinics between 2008 and 2018 were included in the study. Data for demographic characteristics, radiologic evaluations, respiratory support and mechanical ventilation, hospital stay duration, and hospital mortality were retrospectively collected from hospital records.

Results: A total of 117 patients (47 females, 70 males, mean age: 57.3 years) were included in the study. The drowning accidents most commonly occurred in summer (86.3%). Of them, 31 victims (26.4%) were admitted to ICU due to severe respiratory failure. The mean pH was 7.32, and PaO2 was 69.13 mmHg in the arterial blood gas at admission. Invasive and noninvasive mechanical ventilation were performed in 24.7% and 25.6% of the patients respectively. The PaO2/FiO2 of 106 patients (who had accessible FiO2 values) were >300 in 12 (11%), 201-300 in 32 (30%), 101-200 in 49 (46%), and <100 in 13 (12%) patients. Bilateral opacities were observed in 85.4% of the patients. Cardiopulmonary resuscitation was performed in 8 (6.8%) patients. The hospital mortality rate was 6%.

Conclusion: The present study results show that with appropriate therapeutic and support strategies, respiratory failure due to drowning can be treated successfully.

目的:溺水是一种淹没过程,可导致呼吸衰竭。全世界每年估计有 32 万人死于溺水,此外还有非致命性的溺水事件。土耳其有关溺水导致呼吸衰竭及其预后的数据十分有限。本研究旨在确定溺水导致的急性呼吸衰竭(ARF)的治疗方法,以及住院患者的预后:研究纳入了2008年至2018年期间急诊科(ED)或重症监护室(ICU)或肺科住院门诊收治的所有成人溺水病例(根据国际疾病分类(ICD)诊断代码)。研究人员从医院病历中回顾性收集了人口统计学特征、放射学评估、呼吸支持和机械通气、住院时间和住院死亡率等数据:研究共纳入 117 名患者(女性 47 人,男性 70 人,平均年龄 57.3 岁)。溺水事故多发生在夏季(86.3%)。其中,31 名受害者(26.4%)因严重呼吸衰竭而被送入重症监护室。入院时动脉血气的平均 pH 值为 7.32,PaO2 为 69.13 mmHg。分别有 24.7% 和 25.6% 的患者进行了有创和无创机械通气。106 名患者(可获得 FiO2 值)中,PaO2/FiO2>300 的有 12 人(11%),201-300 的有 32 人(30%),101-200 的有 49 人(46%):本研究结果表明,通过适当的治疗和支持策略,可以成功治疗溺水导致的呼吸衰竭。
{"title":"Therapeutic Approaches and Mortality in Acute Respiratory Failure due to Drowning.","authors":"Selin Çakmakcı, Begüm Ergan, Bilgin Cömert, Ali Necati Gökmen","doi":"10.5152/TurkThoracJ.2021.21086","DOIUrl":"10.5152/TurkThoracJ.2021.21086","url":null,"abstract":"<p><strong>Objective: </strong>Drowning is a process of submersion and can lead to respiratory failure. Annually, there are an estimated 320 000 deaths worldwide due to drowning, in addition to nonfatal drowning events. There are limited data for respiratory failure due to drowning and its prognosis in Turkey. The aim of this study was to identify the therapeutic modalities used for acute respiratory failure (ARF) due to drowning, and its prognosis in hospitalized patients.</p><p><strong>Material and methods: </strong>All adult drowning cases (according to the International Classification of Disease (ICD) diagnosis code) who were admitted to either the emergency department (ED) or the intensive care units (ICU), or the pulmonology inpatient clinics between 2008 and 2018 were included in the study. Data for demographic characteristics, radiologic evaluations, respiratory support and mechanical ventilation, hospital stay duration, and hospital mortality were retrospectively collected from hospital records.</p><p><strong>Results: </strong>A total of 117 patients (47 females, 70 males, mean age: 57.3 years) were included in the study. The drowning accidents most commonly occurred in summer (86.3%). Of them, 31 victims (26.4%) were admitted to ICU due to severe respiratory failure. The mean pH was 7.32, and PaO2 was 69.13 mmHg in the arterial blood gas at admission. Invasive and noninvasive mechanical ventilation were performed in 24.7% and 25.6% of the patients respectively. The PaO2/FiO2 of 106 patients (who had accessible FiO2 values) were >300 in 12 (11%), 201-300 in 32 (30%), 101-200 in 49 (46%), and <100 in 13 (12%) patients. Bilateral opacities were observed in 85.4% of the patients. Cardiopulmonary resuscitation was performed in 8 (6.8%) patients. The hospital mortality rate was 6%.</p><p><strong>Conclusion: </strong>The present study results show that with appropriate therapeutic and support strategies, respiratory failure due to drowning can be treated successfully.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"477-481"},"PeriodicalIF":0.8,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975282/pdf/ttj-22-6-477.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39583517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Flow Nasal Oxygen Therapy in Acute Hypoxemic Respiratory Failure: Concise Review on Technology and Initial Methodology. 高流量鼻吸氧治疗急性低氧血症性呼吸衰竭:技术和初步方法的简要回顾。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ.2021.20213
Miguel Guia, Nilgun Alpay, António Gerardo, Yasmin Madney, Mohamed Abdelrahim, Haitham Saeed, Hadeer Harb, Gil Gonçalves, Bruno Cabrita, Jaber Alqahtani, Mohamad El-Khatib, Manuel Gómez-Ríos, Atefeh Fakharian, Laura Ciobanu, Habib Md Reazaul Karim, Edoardo Piervincenzi, Martin Scharffenberg, Paschalis Steiropoulos, William LeMaster, Igor Barjaktarevic, Jakob Wittenstein, Montserrat Diaz-Abad, Andreas Perren, Antonello Nicolini, Savino Spadaro, Giancarlo Garuti, Angelo Petroianni, Antonio Esquinas

High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.

高流量鼻插管氧疗(HFNCOT)系统由一个空气/氧气供应系统组成,能够以高达80升/分钟的流速输送高达100%的加湿和加热氧气。该系统包括搅拌器、主动加湿器、单加热管和鼻插管。与其他标准氧疗相比,HFNCOT具有解剖学上的死腔冲洗、更恒定的吸入氧分数、正呼气末(PEEP)效应、补充充足的湿化和维持纤毛粘膜功能等生理优势。HFNCOT主要用于低氧性急性呼吸衰竭,但也有其他适应症。HFNCOT是医生的普遍选择,因为它的技术使它更安静和舒适。虽然HFNCOT在许多临床环境中使用,但缺乏关于设备和初始设置的出版物。我们对HFNCOT进行了综述,重点介绍了设备和应用方法。
{"title":"High-Flow Nasal Oxygen Therapy in Acute Hypoxemic Respiratory Failure: Concise Review on Technology and Initial Methodology.","authors":"Miguel Guia,&nbsp;Nilgun Alpay,&nbsp;António Gerardo,&nbsp;Yasmin Madney,&nbsp;Mohamed Abdelrahim,&nbsp;Haitham Saeed,&nbsp;Hadeer Harb,&nbsp;Gil Gonçalves,&nbsp;Bruno Cabrita,&nbsp;Jaber Alqahtani,&nbsp;Mohamad El-Khatib,&nbsp;Manuel Gómez-Ríos,&nbsp;Atefeh Fakharian,&nbsp;Laura Ciobanu,&nbsp;Habib Md Reazaul Karim,&nbsp;Edoardo Piervincenzi,&nbsp;Martin Scharffenberg,&nbsp;Paschalis Steiropoulos,&nbsp;William LeMaster,&nbsp;Igor Barjaktarevic,&nbsp;Jakob Wittenstein,&nbsp;Montserrat Diaz-Abad,&nbsp;Andreas Perren,&nbsp;Antonello Nicolini,&nbsp;Savino Spadaro,&nbsp;Giancarlo Garuti,&nbsp;Angelo Petroianni,&nbsp;Antonio Esquinas","doi":"10.5152/TurkThoracJ.2021.20213","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2021.20213","url":null,"abstract":"<p><p>High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"494-500"},"PeriodicalIF":0.9,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975303/pdf/ttj-22-6-494.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39583520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Spontaneous Pneumothorax, Pneumomediastinum, and Subcutaneous Emphysema: Rare Complications in COVID-19 Pneumonia. 自发性气胸、纵隔气肿和皮下肺气肿:COVID-19肺炎的罕见并发症
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ2021.21057
Ibrar Anjum, Noor Fatima Almani, Umer Zia

COVID-19 pneumonia has several complications, such as acute respiratory distress syndrome, septic shock, myocarditis, pulmonary embolism, and thromboembolic stroke. We present a case of a 71-year-old woman who was diagnosed with COVID-19 pneumonia and was found to have a pneumothorax, spontaneous pneumomediastinum (SPM), and subcutaneous emphysema without a history of lung disease. The pathophysiology of SPM and subcutaneous emphysema is likely caused by rupture of the alveolar membrane due to direct damage by COVID-19 infection and frequent cough-induced barotrauma.

COVID-19肺炎有多种并发症,如急性呼吸窘迫综合征、感染性休克、心肌炎、肺栓塞和血栓栓塞性中风。我们报告了一例71岁的女性,她被诊断为COVID-19肺炎,并被发现有气胸、自发性纵隔气肿(SPM)和皮下肺气肿,没有肺部疾病史。SPM和皮下肺气肿的病理生理可能是由COVID-19感染直接损伤肺泡膜破裂和频繁咳嗽引起的气压损伤引起的。
{"title":"Spontaneous Pneumothorax, Pneumomediastinum, and Subcutaneous Emphysema: Rare Complications in COVID-19 Pneumonia.","authors":"Ibrar Anjum,&nbsp;Noor Fatima Almani,&nbsp;Umer Zia","doi":"10.5152/TurkThoracJ2021.21057","DOIUrl":"https://doi.org/10.5152/TurkThoracJ2021.21057","url":null,"abstract":"<p><p>COVID-19 pneumonia has several complications, such as acute respiratory distress syndrome, septic shock, myocarditis, pulmonary embolism, and thromboembolic stroke. We present a case of a 71-year-old woman who was diagnosed with COVID-19 pneumonia and was found to have a pneumothorax, spontaneous pneumomediastinum (SPM), and subcutaneous emphysema without a history of lung disease. The pathophysiology of SPM and subcutaneous emphysema is likely caused by rupture of the alveolar membrane due to direct damage by COVID-19 infection and frequent cough-induced barotrauma.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"507-509"},"PeriodicalIF":0.9,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975313/pdf/ttj-22-6-507.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39583522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Persistent Ambient Air Pollution in Turkey: A 4-Year Analysis. 土耳其持续的环境空气污染:4年分析。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ.2021.21121
Nilüfer Aykaç, Yeşim Yasin

Objective: Ambient air pollution is an important cause of morbidity and mortality for both individual and public health. The major contaminant that creates air pollution in Turkey is particulate matter. This study aims to demonstrate Turkey's air quality in terms of particulatematter in the last 4 years.

Material and methods: In this descriptive study, the public data of the National Air Quality Monitoring Network between the years 2016 and 2019 were analyzed for particulate matter (PM10). Stations with less than 75% data throughout the year were excluded from the evaluation while calculating the annual average values. The averages of the years were compared statistically with each other.

Results: For 111 stations that made sufficient measurements for 4 years, the annual median value of particulate matter remained constant in 12 stations (10.8%), increased in 26 stations (23.4%), and decreased in 73 stations (65.7%). The level of air pollution at 18 stations has been sustained for 4 years. It has been observed that there is no significant improvement in the criterion that the daily average PM10 level should not be higher than 50 μg/m3 for more than 35 days, and pollution is detected above the limit value permitted by the World Health Organization in all provinces and stations except a few provinces every year. Finally, during the 4-year observation, the number of stations that did not make sufficient measurements throughout the year has been found to increase over the years.

Conclusion: Our data reveal that the air pollution attributable to particulate matter in Turkey between the years 2016 and 2019 did not regress prominently. On the contrary, air pollution has been found to gain permanency in certain provinces, and air quality monitoring has been inadequate due to insufficient measurement activities of some of the stations.

目的:环境空气污染是造成个人和公众健康发病率和死亡率的重要原因。造成土耳其空气污染的主要污染物是颗粒物。本研究旨在展示土耳其在过去4年的空气质量方面的颗粒物。材料和方法:在这项描述性研究中,对2016年至2019年国家空气质量监测网的公共数据进行了颗粒物(PM10)分析。在计算年平均值时,全年数据低于75%的站点被排除在评估之外。这些年的平均值在统计上相互比较。结果:在4年充分观测的111个站点中,颗粒物年中位数保持不变的站点有12个(10.8%),上升的站点有26个(23.4%),下降的站点有73个(65.7%)。18个监测站的空气污染水平已持续4年。我们观察到,每日平均PM10浓度不超过50 μg/m3超过35天的标准没有明显改善,除少数省份外,每年所有省份和站点的污染检测都超过世界卫生组织允许的限值。最后,在4年的观测期间,发现全年没有进行充分测量的台站数量逐年增加。结论:我们的数据显示,2016年至2019年期间,土耳其由颗粒物引起的空气污染并没有明显消退。相反,在某些省份发现空气污染长期存在,由于一些监测站的测量活动不足,空气质量监测不足。
{"title":"Persistent Ambient Air Pollution in Turkey: A 4-Year Analysis.","authors":"Nilüfer Aykaç,&nbsp;Yeşim Yasin","doi":"10.5152/TurkThoracJ.2021.21121","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2021.21121","url":null,"abstract":"<p><strong>Objective: </strong>Ambient air pollution is an important cause of morbidity and mortality for both individual and public health. The major contaminant that creates air pollution in Turkey is particulate matter. This study aims to demonstrate Turkey's air quality in terms of particulatematter in the last 4 years.</p><p><strong>Material and methods: </strong>In this descriptive study, the public data of the National Air Quality Monitoring Network between the years 2016 and 2019 were analyzed for particulate matter (PM10). Stations with less than 75% data throughout the year were excluded from the evaluation while calculating the annual average values. The averages of the years were compared statistically with each other.</p><p><strong>Results: </strong>For 111 stations that made sufficient measurements for 4 years, the annual median value of particulate matter remained constant in 12 stations (10.8%), increased in 26 stations (23.4%), and decreased in 73 stations (65.7%). The level of air pollution at 18 stations has been sustained for 4 years. It has been observed that there is no significant improvement in the criterion that the daily average PM10 level should not be higher than 50 μg/m3 for more than 35 days, and pollution is detected above the limit value permitted by the World Health Organization in all provinces and stations except a few provinces every year. Finally, during the 4-year observation, the number of stations that did not make sufficient measurements throughout the year has been found to increase over the years.</p><p><strong>Conclusion: </strong>Our data reveal that the air pollution attributable to particulate matter in Turkey between the years 2016 and 2019 did not regress prominently. On the contrary, air pollution has been found to gain permanency in certain provinces, and air quality monitoring has been inadequate due to insufficient measurement activities of some of the stations.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"482-488"},"PeriodicalIF":0.9,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975334/pdf/ttj-22-6-482.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39583518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 and Tuberculosis: Is It a Syndemic Situation? COVID-19和结核病:这是一种综合征吗?
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ.2021.21113
Serir Özkan
{"title":"COVID-19 and Tuberculosis: Is It a Syndemic Situation?","authors":"Serir Özkan","doi":"10.5152/TurkThoracJ.2021.21113","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2021.21113","url":null,"abstract":"","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"512-513"},"PeriodicalIF":0.9,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975316/pdf/ttj-22-6-512.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39583525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Therapeutic Effects of a Pigtail Catheter and Chest Tube in the Treatment of Spontaneous Pneumothorax: A Randomized Clinical Trial Study. 猪尾管与胸管治疗自发性气胸的疗效比较:一项随机临床研究。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ.2021.20281
Seyed Ziaeddin Rasihashemi, Ali Ramouz, Hassan Amini

Objective: The purpose of this study was to compare the therapeutic effects of a pigtail catheter with a chest tube in the management of patients with spontaneous pneumothorax (SP).

Material and methods: A randomized controlled trial study was performed on patients with SP from August 2016 to December 2017 at Imam Reza Hospital, Tabriz, Iran. Forty-four patients were randomly assigned into 2 groups: group A with a 14-Fr pigtail catheter and group B using a 28-Fr chest tube. Two patients were excluded from the study.

Results: Forty-two patients participated in the study with 21 patients in each group. There were no significant differences between the groups in the patients' baseline data. The success rate was higher in patients with pigtail catheters (85.7%) than in patients with chest tubes (76.2%). However, the difference was not significant (P = .43). The procedure time was significantly shorter in the pigtail group compared to the chest tube group (P < .01). According to the visual analog scale (VAS), patients with pigtail catheters experienced milder pain during tube insertion than patients with chest tubes (P = .02). However, the pain score at the insertion site was not significantly different between the 2 groups for the first 2 days after the procedure. Patients with pigtail catheters experienced significantly less pain than patients with chest tubes during removal of the tube (P < .01). Also, there was no significant difference between the pain experienced by the 2 groups at the time of hospital discharge (P = .19). Analgesic drug usage was lower in patients with pigtail catheters compared to patients with chest tubes (P < .01). There was a trend toward lower median hospital stays demonstrated by patients with pigtail catheters compared to patients with chest tubes (P = .2).

Conclusion: Pigtail catheters might be as effective as chest tubes for treating patients with SP in terms of lung re-expansion.

目的:本研究的目的是比较猪尾导管与胸管在治疗自发性气胸(SP)患者中的疗效。材料与方法:2016年8月至2017年12月在伊朗大不里士伊玛目礼萨医院对SP患者进行随机对照试验研究。44例患者随机分为2组:A组采用14fr细尾导管,B组采用28fr胸管。两名患者被排除在研究之外。结果:共42例患者参与研究,每组21例。两组患者的基线数据无显著差异。使用短尾导管的成功率(85.7%)高于使用胸管的成功率(76.2%)。但差异无统计学意义(P = 0.43)。辫子组手术时间明显短于胸管组(P < 0.01)。根据视觉模拟评分(visual analogue scale, VAS),猪尾管患者在置管过程中疼痛程度较胸管患者轻(P = 0.02)。然而,在手术后的前2天,两组在插入部位的疼痛评分没有显著差异。在拔管过程中,使用辫状导管的患者比使用胸管的患者疼痛明显减轻(P < 0.01)。两组患者出院时疼痛程度差异无统计学意义(P = 0.19)。使用猪尾导管的患者镇痛药物用量低于使用胸管的患者(P < 0.01)。与胸管患者相比,使用辫子导管的患者的住院时间中位数较低(P = 0.2)。结论:猪尾导管治疗SP患者肺再扩张的效果与胸管相同。
{"title":"Comparison of the Therapeutic Effects of a Pigtail Catheter and Chest Tube in the Treatment of Spontaneous Pneumothorax: A Randomized Clinical Trial Study.","authors":"Seyed Ziaeddin Rasihashemi,&nbsp;Ali Ramouz,&nbsp;Hassan Amini","doi":"10.5152/TurkThoracJ.2021.20281","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2021.20281","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to compare the therapeutic effects of a pigtail catheter with a chest tube in the management of patients with spontaneous pneumothorax (SP).</p><p><strong>Material and methods: </strong>A randomized controlled trial study was performed on patients with SP from August 2016 to December 2017 at Imam Reza Hospital, Tabriz, Iran. Forty-four patients were randomly assigned into 2 groups: group A with a 14-Fr pigtail catheter and group B using a 28-Fr chest tube. Two patients were excluded from the study.</p><p><strong>Results: </strong>Forty-two patients participated in the study with 21 patients in each group. There were no significant differences between the groups in the patients' baseline data. The success rate was higher in patients with pigtail catheters (85.7%) than in patients with chest tubes (76.2%). However, the difference was not significant (P = .43). The procedure time was significantly shorter in the pigtail group compared to the chest tube group (P < .01). According to the visual analog scale (VAS), patients with pigtail catheters experienced milder pain during tube insertion than patients with chest tubes (P = .02). However, the pain score at the insertion site was not significantly different between the 2 groups for the first 2 days after the procedure. Patients with pigtail catheters experienced significantly less pain than patients with chest tubes during removal of the tube (P < .01). Also, there was no significant difference between the pain experienced by the 2 groups at the time of hospital discharge (P = .19). Analgesic drug usage was lower in patients with pigtail catheters compared to patients with chest tubes (P < .01). There was a trend toward lower median hospital stays demonstrated by patients with pigtail catheters compared to patients with chest tubes (P = .2).</p><p><strong>Conclusion: </strong>Pigtail catheters might be as effective as chest tubes for treating patients with SP in terms of lung re-expansion.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"459-465"},"PeriodicalIF":0.9,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975284/pdf/ttj-22-6-459.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39758462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Tobacco Containing Scenes in Some Selected Turkish Movies Released Between 1992 and 2016. 1992年至2016年上映的一些精选土耳其电影中含有烟草的场景。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ.2021.20291
Hanife Ece Erik, Merve Colaklar, Egemen Yildiz, Aişe Esra Gülçek, Bilgin Percin, Cağlar Aktas, Cağrı Özbeyaz, Fati Gözde Sebnem Tokmak, Mervenur Demir Çuha, Mustafa Doğru, Polat Ercan, Aslı Kuzu, Deniz Aral Özbek, Eda Dölek, Fadime Eda Koç, Büşra Solak, Mahmut Yardım, Hilal Özcebe

Objective: Movies are among the most widely used media for advertising, promotional, and sponsorship activities of the tobacco industry, and the industry has been making huge investments in this sector for many years. In this study, the effects of movie scenes depicting the use of tobacco products, and the possible effects of the laws governing such scenes, were examined.

Material and methods: The sample of the study consisted of 50 films, the first 2 of which were the most watched each year, between the years 1992 and 2016, according to the data of the Center for Turkish Cinema Studies and the boxofficeturkiye.com websites. The scenes depicting the use of tobacco products were analyzed using the data collection form developed by the researchers. Each movie was evaluated separately by 2 researchers.

Results: A tobacco product was used in 82% of the 50 films watched. Men (87%), individuals between the ages of 25 and 64 (78.0%), and leading actors (40%) used more tobacco products, and the most frequently used product was the cigarette (93.1%). The number andduration of scenes containing tobacco was greater by 1.6 times before the first law was passed, and between the passage of the first law and the passage of the second law (P > .05, P > .05). The number and duration of the scenes decreased between the passage of the first and the second laws and after the second law was passed, by 3.6 and 5.3 times, respectively (P < .05, P < .05).

Conclusion: Consistent and comprehensive tobacco control policies have been effective in reducing the number of scenes that contain tobacco in the movies produced in Turkey. A comprehensive and multidisciplinary approach is required to overcome the tobacco industry's impact on cinema.

目的:电影是烟草行业广告、促销和赞助活动中使用最广泛的媒体之一,烟草行业多年来一直在这一领域进行巨额投资。在这项研究中,研究了描绘烟草产品使用的电影场景的影响,以及管理此类场景的法律可能产生的影响。材料和方法:根据土耳其电影研究中心和boxofficeturkiye.com网站的数据,研究样本包括50部电影,其中前两部是1992年至2016年间每年观看人数最多的电影。使用研究人员开发的数据收集表格对描绘烟草产品使用的场景进行了分析。每部电影分别由2名研究人员进行评估。结果:在观看的50部电影中,有82%使用了烟草制品。男性(87%)、25岁至64岁人群(78.0%)和主要演员(40%)使用更多的烟草制品,最常使用的产品是香烟(93.1%)。烟草场景的数量和持续时间在第一法律通过前、第一法律通过与第二法律通过之间是1.6倍(P > 0.05, P > 0.05)。在第一法和第二法通过期间和第二法通过后,场景数量和时长分别减少了3.6倍和5.3倍(P < 0.05, P < 0.05)。结论:一贯和全面的控烟政策在减少土耳其制作的电影中含有烟草的场景数量方面是有效的。需要一种全面和多学科的方法来克服烟草业对电影的影响。
{"title":"Tobacco Containing Scenes in Some Selected Turkish Movies Released Between 1992 and 2016.","authors":"Hanife Ece Erik,&nbsp;Merve Colaklar,&nbsp;Egemen Yildiz,&nbsp;Aişe Esra Gülçek,&nbsp;Bilgin Percin,&nbsp;Cağlar Aktas,&nbsp;Cağrı Özbeyaz,&nbsp;Fati Gözde Sebnem Tokmak,&nbsp;Mervenur Demir Çuha,&nbsp;Mustafa Doğru,&nbsp;Polat Ercan,&nbsp;Aslı Kuzu,&nbsp;Deniz Aral Özbek,&nbsp;Eda Dölek,&nbsp;Fadime Eda Koç,&nbsp;Büşra Solak,&nbsp;Mahmut Yardım,&nbsp;Hilal Özcebe","doi":"10.5152/TurkThoracJ.2021.20291","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2021.20291","url":null,"abstract":"<p><strong>Objective: </strong>Movies are among the most widely used media for advertising, promotional, and sponsorship activities of the tobacco industry, and the industry has been making huge investments in this sector for many years. In this study, the effects of movie scenes depicting the use of tobacco products, and the possible effects of the laws governing such scenes, were examined.</p><p><strong>Material and methods: </strong>The sample of the study consisted of 50 films, the first 2 of which were the most watched each year, between the years 1992 and 2016, according to the data of the Center for Turkish Cinema Studies and the boxofficeturkiye.com websites. The scenes depicting the use of tobacco products were analyzed using the data collection form developed by the researchers. Each movie was evaluated separately by 2 researchers.</p><p><strong>Results: </strong>A tobacco product was used in 82% of the 50 films watched. Men (87%), individuals between the ages of 25 and 64 (78.0%), and leading actors (40%) used more tobacco products, and the most frequently used product was the cigarette (93.1%). The number andduration of scenes containing tobacco was greater by 1.6 times before the first law was passed, and between the passage of the first law and the passage of the second law (P > .05, P > .05). The number and duration of the scenes decreased between the passage of the first and the second laws and after the second law was passed, by 3.6 and 5.3 times, respectively (P < .05, P < .05).</p><p><strong>Conclusion: </strong>Consistent and comprehensive tobacco control policies have been effective in reducing the number of scenes that contain tobacco in the movies produced in Turkey. A comprehensive and multidisciplinary approach is required to overcome the tobacco industry's impact on cinema.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"432-438"},"PeriodicalIF":0.9,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975287/pdf/ttj-22-6-432.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39758458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turkish Thoracic Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1